Accepted for Publication: October 30, 2013.
Published Online: June 11, 2014. doi:10.1001/jamadermatol.2013.9411.
Study concept and design: Lebrun-Frénay, Tartare-Deckert, Passeron.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Pharaon, Tichet, Lebrun-Frénay.
Critical revision of the manuscript for important intellectual content: Pharaon, Lebrun-Frénay, Tartare-Deckert, Passeron.
Statistical analysis: Pharaon, Tichet.
Obtained funding: Tartare-Deckert.
Administrative, technical, or material support: Lebrun-Frénay, Tartare-Deckert, Passeron.
Study supervision: Lebrun-Frénay, Tartare-Deckert, Passeron.
Conflict of Interest Disclosures: Dr Lebrun-Frénay participated in meetings sponsored by and received honoraria for lectures, advisory board participation, and consultations from Allergan, Almirall, Biogen Idec, Bayer Schering, Genzyme, Merck Serono, Novartis, sanofi-aventis, and Teva. Dr Passeron participated in meetings sponsored by and received honoraria for lectures, advisory board participation, and consultations from Abbott, Almirall, Bioderma, Candela/Syneron, Beiersdorf, Galderma, GSK, Jansen, L’Oreal, Léo-Pharma, Merck, Pierre Fabre, Pfizer, and Sinclair-Pharma. No other disclosures were reported.
Funding/Support: This study was supported by INSERM and the Fondation ARC.
Role of the Sponsors: The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: We thank the C3M imaging core facility (Microscopy and Imaging platform Côte d’Azur [MICA]) for immunofluorescent analysis. Emeline Castela, MD (Department of Dermatology, CHU Nice), Muriel Laffon, MD (Department of Neurology, CHU Nice), Philippe Bahadoran, MD, PhD (Department of Dermatology and Centre de Recherche Clinique, CHU Nice), Fanny Rocher, PharmD (Centre de Pharmacovigilance, CHU Nice), Mikael Cohen, MD (Department of Neurology, CHU Nice), Patricia Abbe, BSc (INSERM, U1065, Team 11, C3M), Nathalie Cardot-Leccia, MD (Department of Pathology, CHU Nice), and Jean-Philippe Lacour, MD (Department of Dermatology, CHU Nice), provided medical and technical help. None received financial compensation for their services.